Heather Leach, PhD


Parkinson’s disease: Unmet needs to be fulfilled by novel therapies and reformulations

July 23, 2015

The current global Parkinson’s disease market is characterized by a number of unmet needs, which include addressing the motor complications of dyskinesia and off-episodes. The recent approval of novel therapies and reformulations of existing drugs has the potential to fulfill some of these unmet needs, particularly in patients with advanced disease.